Acorda Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 21 shareholders own 10.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.44%	Davidson Kempner Capital Management LP	55,145	US$1.7k	0%	no data
2.71%	Acadian Asset Management LLC	33,691	US$1.0k	0%	no data
1.55%	The Vanguard Group, Inc.	19,260	US$579.7	78.2%	no data
0.6%	Ron Cohen	7,488	US$225.4	0%	no data
0.49%	BlackRock, Inc.	6,107	US$183.8	-7.86%	no data
0.31%	Bridgeway Capital Management, LLC	3,836	US$115.5	0%	no data
0.3%	Wells Fargo & Company, Securities and Brokerage Investments	3,726	US$112.2	-0.13%	no data
0.092%	Morgan Stanley, Investment Banking and Brokerage Investments	1,137	US$34.2	-3.15%	no data
0.041%	Kerry Clem	504	US$15.2	0%	no data
0.0085%	UBS Asset Management AG	106	US$3.2	-64.4%	no data
0.0083%	Tower Research Capital Europe Limited	103	US$3.1	0%	no data
0.0041%	Merrill Lynch & Co. Inc., Banking Investments	51	US$1.5	2%	no data
0.0019%	Sandra Panem	24	US$0.7	0%	no data
0.001%	RBC Dominion Securities Inc., Asset Management Arm	13	US$0.4	0%	no data
0.00081%	Wells Fargo & Company, Private Banking and Investment Banking Arm	10	US$0.3	0%	no data
0.00072%	Strategic Advisers LLC	9	US$0.3	0%	no data
0.00032%	JPMorgan Chase & Co, Brokerage and Securities Investments	4	US$0.1	33.3%	no data
0.00024%	First Manhattan Co. LLC	3	US$0.09	0%	no data
0.00008%	Qube Research & Technologies Ltd	1	US$0.03	0%	no data
0.00008%	Royal Bank of Canada, Banking & Securities Investments	1	US$0.03	0%	no data
0.00008%	Osaic Wealth, Inc. , Asset Management Arm	1	US$0.03	0%	no data